| 1 |
31313842 | A loop involving NRF2, miR-29b-1-5p and AKT, regulates cell fate of MDA-MB-231 triple-negative breast cancer cells. | 2020 Feb |
1 |
| 2 |
29354292 | Parthenolide prevents resistance of MDA-MB231 cells to doxorubicin and mitoxantrone: the role of Nrf2. | 2017 |
1 |
| 3 |
27573247 | Rational Design of a Parthenolide-based Drug Regimen That Selectively Eradicates Acute Myelogenous Leukemia Stem Cells. | 2016 Oct 14 |
1 |
| 4 |
25370819 | The synergistic effect of SAHA and parthenolide in MDA-MB231 breast cancer cells. | 2015 Jun |
2 |
| 5 |
20368435 | Nrf2 responses and the therapeutic selectivity of electrophilic compounds in chronic lymphocytic leukemia. | 2010 Apr 20 |
1 |
| 6 |
20938215 | Enhancement of parthenolide-induced apoptosis by a PKC-alpha inhibition through heme oxygenase-1 blockage in cholangiocarcinoma cells. | 2010 Nov 30 |
2 |